跳至主要内容
临床试验/NCT02135120
NCT02135120已完成不适用

Do Peripheral Nerve Blocks When Used as Part of a Multimodal Regimen Inclusive on Intrathecal Morphine Improve Analgesia After Unilateral Total Knee Arthroplasty? A Randomized Controlled Trial

American University of Beirut Medical Center1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2013年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
1
主要终点
Postoperative parenteral morphine consumption

研究概览

简要总结

The purpose of this study is to determine whether intrathecal morphine (ITM) alone or its combination with peripheral nerve blocks (PNB) provides better analgesia for patients undergoing total knee arthroplasty (TKA).

详细描述

Total knee arthroplasty (TKA) surgery is associated with severe pain. The success of knee rehabilitation following surgery depends largely on adequate pain control that permits early physical therapy. Postoperative modern analgesic recommendations specific to TKA propose either spinal block with intrathecal morphine (ITM) or a combination of general anesthesia with single shot femoral nerve block (SFNB). Femoral nerve block (FNB) too has proven analgesic advantages in TKA surgery. However, we do not know if the combination of the two analgesic techniques, ITM and peripheral nerve blocks (PNB), provides superior analgesia to ITM alone.

Thus, this study aims to determine whether ITM alone or its combination with PNB provides better analgesia for patients undergoing total knee arthroplasty (TKA).

Eligible patients undergoing unilateral TKA under spinal anesthesia consenting to a multimodal analgesic regimen inclusive of ITM, FNB, and SNB will be recruited. All patients will receive spinal with intrathecal morphine. Patients will be randomly assigned using a computer generated table of random numbers to receive either spinal with intrathecal morphine (morphine group), a combination of intrathecal morphine and femoral nerve block (morphine-femoral group), or a combination of intrathecal morphine and femoral nerve block as well as sciatic nerve block (morphine-femoral-sciatic group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-III patients undergoing unilateral TKA under spinal anesthesia and nerve blocks
  • Ages 18-80
  • BMI ≤ 38 kg/m2

排除标准

  • BMI > 38 kg/m2
  • chronic pain disorders
  • Significant pre-existing neurological deficits or peripheral neuropathy affecting the lower extremity
  • abuse of drugs or alcohol
  • Contraindication to a component of multi-modal analgesia
  • Contraindication to spinal anesthesia or failure to institute spinal anesthesia after performing femoral and sciatic blocks
  • Bilateral TKA surgeries
  • History of significant psychiatric conditions that may affect patient assessment
  • Pregnancy
  • Moderate to severe obstructive sleep apnea.
  • Previous adverse reactions resulting from intrathecal opioids (respiratory depression, urinary retention, severe pruritis, severe nausea or vomiting, severe sedation)
  • inability to provide informed consent.

研究组 & 干预措施

Morphine group

Active Comparator

Patients will receive a combined spinal epidural anesthesia technique with intrathecal morphine

干预措施: Combined spinal epidural anesthesia technique with intrathecal morphine (Drug)

Morphine-femoral group

Active Comparator

Patients will receive a combination of combined spinal-epidural (with intrathecal morphine) and femoral nerve block

干预措施: A combination of combined spinal-epidural (with intrathecal morphine) and femoral nerve block (Drug)

Morphine-femoral-sciatic group

Active Comparator

Patients will receive a combination of combined spinal-epidural (with intrathecal morphine) and femoral nerve block as well as sciatic nerve block

干预措施: A combination of combined spinal-epidural (with intrathecal morphine) and femoral nerve block as well as sciatic nerve block (Drug)

结局指标

主要结局

Postoperative parenteral morphine consumption

时间窗: first 24 hours post-operation

次要结局

  • Visual analogue pain scores (VAS) in anterior and posterior knee(within 24-48 hours after surgery)
  • Severity of pain in anterior and posterior knee(1 week postoperatively)
  • Time to first IV PCA bolus(within first 12 hours)
  • Total IV PCA consumption upon discontinuation of PCA(24-48 hours after surgery)
  • Side effects(within 24 hours after surgery)
  • Patient satisfaction with pain control(24-48 hours after surgery)
  • complications(1 month after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ghassan Kanazi

Professor and Chairman

American University of Beirut Medical Center

研究点 (1)

Loading locations...

相似试验